Brown Carl J, Dubreuil Daniel, Santoro Laura, Liu Maria, O'Connor Brenda I, McLeod Robin S
Department of Surgery, Mount Sinai Hospital and University of Toronto, Toronto, Canada.
Dis Colon Rectum. 2007 Apr;50(4):442-8. doi: 10.1007/s10350-006-0844-3.
Although there is enthusiasm for nonoperative management of anal fissures, most trials have been of short duration (6-8 weeks) and long-term outcome is unknown. The purpose of this study was to assess long-term outcome in two cohorts of patients who had participated in a randomized, controlled trial to compare the effectiveness of topical nitroglycerin with internal sphincterotomy in the treatment of chronic anal fissure.
Between February 1997 and October 1998, 82 patients with chronic anal fissure were accrued and randomized to 0.25 percent nitroglycerin ointment t.i.d. or lateral internal sphincterotomy. In 2004, a telephone survey of trial participants was conducted to determine symptom recurrence, the need for further medical and/or surgical treatment, and patient satisfaction. Furthermore, patients were assessed for symptoms of fecal incontinence using the Jorge and Wexner Fecal Incontinence Score and the Fecal Incontinence Quality of Life questionnaire.
Overall, 51 of the original 82 patients (62 percent, 27 nitroglycerin, 24 lateral internal sphincterotomy) completed our survey. Mean follow-up was 79 (+/-1) months. Sphincterotomy patients were less likely to have experienced fissure symptoms within the past year (0 vs. 41 percent; P = 0.0004) and were less likely to require subsequent surgical treatment (0 vs. 59 percent; P < 0.0001) than patients treated with nitroglycerin. Patients in the lateral internal sphincterotomy group were more likely to say that they were "very" or "moderately" satisfied with their treatment (100 vs. 56 percent; P = 0.04) and that they would choose the same treatment again (92 vs. 63 percent; P = 0.02) than patients in the nitroglycerin group. Finally, the fecal incontinence and fecal incontinence quality of life scores at six-year follow-up were similar in both groups.
After six years of follow-up, it seems that lateral internal sphincterotomy is a more durable treatment for chronic anal fissure compared with topical nitroglycerin therapy and does not compromise long-term fecal continence. Thus, sphincterotomy continues to be a good treatment for patients with chronic anal fissure.
尽管人们对肛裂的非手术治疗充满热情,但大多数试验持续时间较短(6 - 8周),长期疗效尚不清楚。本研究的目的是评估两组参与随机对照试验的患者的长期疗效,该试验比较了局部应用硝酸甘油与内括约肌切开术治疗慢性肛裂的有效性。
在1997年2月至1998年10月期间,招募了82例慢性肛裂患者,并随机分为每日三次使用0.25%硝酸甘油软膏组或外侧内括约肌切开术组。2004年,对试验参与者进行了电话调查,以确定症状复发情况、是否需要进一步的药物和/或手术治疗以及患者满意度。此外,使用豪尔赫和韦克斯纳大便失禁评分以及大便失禁生活质量问卷对患者的大便失禁症状进行评估。
总体而言,最初的82例患者中有51例(62%,硝酸甘油组27例,外侧内括约肌切开术组24例)完成了我们的调查。平均随访时间为79(±1)个月。与接受硝酸甘油治疗的患者相比,内括约肌切开术组患者在过去一年中出现肛裂症状的可能性较小(0%对41%;P = 0.0004),且需要后续手术治疗的可能性也较小(0%对59%;P < 0.0001)。外侧内括约肌切开术组患者比硝酸甘油组患者更有可能表示对治疗“非常”或“中度”满意(100%对56%;P = 0.04),并且更有可能再次选择相同的治疗方法(92%对63%;P = 0.02)。最后,两组在六年随访时的大便失禁及大便失禁生活质量评分相似。
经过六年的随访,与局部应用硝酸甘油治疗相比,外侧内括约肌切开术似乎是一种更持久的慢性肛裂治疗方法,且不影响长期的大便自控能力。因此,内括约肌切开术仍然是慢性肛裂患者的一种良好治疗方法。